Evidence map›Paper›PMID 35409640›Full record

ArticleInternational journal of environmental research and public health2022

COVID-19 Lockdown in Patients with Chronic Diseases: A Cross-Sectional Study.

Mathieu Boulin, Amélie Cransac-Miet, Marc Maynadié, Fabienne Volot, Catherine Creuzot-Garcher, Jean-Christophe Eicher, Frédéric Chagué, Eléa Ksiazek, Guillaume Beltramo, Philippe Bonniaud and 6 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04390126 (COVID-19 Related Lockdown Effects On Chronic Diseases), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04390126 completednot on this map

COVID-19 Related Lockdown Effects On Chronic Diseases

TypeobservationalSponsorCentre Hospitalier Universitaire DijonRan2020 to 2020Enrolled1,343ConditionsChronic Coronary Syndrome, Heart Failure, AMD and Macular Edema, Chronic Respiratory FailureArmslife questionnaires, questionnaire
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Mobile Device Usage before and during the COVID-19 Pandemic among Rural and Urban Adults.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Mathieu BoulinPharmacy Department, Dijon Bourgogne University Hospital, EPICAD LNC UMR 1231, 21000 Dijon, France.ORCID 0000-0002-3504-7250
Amélie Cransac-MietPharmacy Department, Dijon Bourgogne University Hospital, EPICAD LNC UMR 1231, 21000 Dijon, France.ORCID 0000-0003-1836-2619
Marc MaynadiéBiological Haematology Department, Dijon Bourgogne University Hospital, Haematological Malignancies Registry, LNC UMR 1231, 21000 Dijon, France.
Fabienne VolotHaemophilia Comprehensive Care Centre, Dijon Bourgogne University Hospital, 21000 Dijon, France.
Catherine Creuzot-GarcherEye and Nutrition Research Group, Ophthalmology Department, Dijon Bourgogne University Hospital, UMR1324, INRAE, 6265 CNRS, 21000 Dijon, France.
Jean-Christophe EicherCardiology Department, Dijon Bourgogne University Hospital, 21000 Dijon, France.
Frédéric ChaguéCardiology Department, Dijon Bourgogne University Hospital, 21000 Dijon, France.ORCID 0000-0003-4841-3253
Eléa KsiazekDepartment of Clinical Research and Innovation (DRCI), Clinical Research Unit-Methodological Support Network (USMR), Dijon Bourgogne University Hospital, 21000 Dijon, France.
Guillaume BeltramoReference Constitutive Center for Rare Pulmonary Diseases, Pulmonary Medicine and Intensive Care Unit Department, Dijon Bourgogne University Hospital, LNC UMR 1231, 21000 Dijon, France.
Philippe BonniaudReference Constitutive Center for Rare Pulmonary Diseases, Pulmonary Medicine and Intensive Care Unit Department, Dijon Bourgogne University Hospital, LNC UMR 1231, 21000 Dijon, France.ORCID 0000-0002-3670-5622
Thibault MoreauNeurology Department, Dijon Bourgogne University Hospital, Bio-PeroxyIL, EA 7270, 21000 Dijon, France.
Bernard BonnotteDepartment of Internal Medicine and Clinical Immunology, Dijon Bourgogne University Hospital, INSERM U1098, 21000 Dijon, France.ORCID 0000-0001-7229-3808
Edith Sales-WuilleminPsy-DREPI (Psychologie: Dynamiques Relationnelles et Processus Pdentitaires), University of Bourgogne Franche-Comté, EA 7458, 21000 Dijon, France.ORCID 0000-0001-9844-3800
Agnès Soudry-FaureDepartment of Clinical Research and Innovation (DRCI), Clinical Research Unit-Methodological Support Network (USMR), Dijon Bourgogne University Hospital, 21000 Dijon, France.
Marianne ZellerCardiology Department, Dijon Bourgogne University Hospital, PEC2, EA 7460, 21000 Dijon, France.ORCID 0000-0002-5763-4579
Yves CottinCardiology Department, Dijon Bourgogne University Hospital, PEC2, EA 7460, 21000 Dijon, France.
Université de Bourgogne · FRCentre National de la Recherche Scientifique · FRCHU Dijon Bourgogne · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: We aimed to investigate the impact of the first COVID-19 lockdown on medication adherence, physician access, lifestyle behaviours, and mental health in patients with chronic conditions. Methods: A cross-sectional phone survey was conducted in 1274 housebound adults recruited from 8 regional chronic disease cohorts (CLEO CD study: NCT04390126). Results: Medication adherence was 97%; 305 (41%) patients declared that at least one scheduled visit with a physician was missed during the first lockdown. The main changes in lifestyle behaviours were deterioration in sleep time (duration and/or quality; 71%), increase in screen time (46%), and decrease in physical activity (46%). Nineteen percent experienced psychological distress (Kessler-6 score ≥ 5). An urban living place (OR, 1.76 vs. rural; 95% CI, 1.32−2.33; p = 10−4), worse self-reported mental health (OR, 1.62 vs. about the same or better; 95% CI, 1.17−2.25; p = 0.003), and a K6 score ≥ 5 (OR, 1.52 vs. <5; 95% CI, 1.05−2.21; p = 0.03) were independent factors associated with at least one unhealthy behaviour. Conclusions: Encouraging results were observed in terms of medication adherence. Caution is needed in chronic disease patients living in urban places as well as those presenting psychological distress and worse self-reported mental health to reduce unhealthy behaviours.

Indexed as

COVID-19AdultChronic DiseaseCommunicable Disease ControlCross-Sectional StudiesHumansLife Stylechronic diseasesCOVID-19lifestyle behaviourslockdownmedication adherencemental healthphysician accessunhealthy behaviours

Identifiers

PMID35409640
PMCPMC8997956
OpenAlexW4221061196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.